The FDA approved a new daily HIV pill by Gilead for patients already on effective single-pill regimens, allowing for easier switching to new treatments.
מקור: Business News — לכתבה המלאה

The FDA approved a new daily HIV pill by Gilead for patients already on effective single-pill regimens, allowing for easier switching to new treatments.
מקור: Business News — לכתבה המלאה
כתיבת תגובה